Healthcare providers-along with companies involved in life sciences and healthcare information technology-consider Hunter Rost a trusted advisor. Working side-by-side with company owners and management, Hunter takes a "hands-on" approach to transactional matters and interacts with clients on a personal level. By recognizing what the client considers most important, and understanding his or her risk tolerance, Hunter focuses on key priorities to keep deals moving forward efficiently and cost-effectively.
Hunter counsels clients on a variety of corporate transactions, including:
· Corporate reorganizations and recapitalizations
· Domestic and cross-border mergers and acquisitions
· Intellectual property transactions
· Joint ventures
· Private equity financings
· Public and private securities offerings
Private equity and venture capital firms rely on Hunter's extensive experience with change of control issues and deal terms when making investments in biotechnology, pharmaceutical, medical device, healthcare, and healthcare IT companies. Likewise, corporate management and directors turn to Hunter for counsel on strategic transactions, fiduciary duties, and corporate governance matters for his appreciation of their objectives, and his commitment to achieving positive results.
Hunter is Waller's representative to World Services Group, a global membership association of independent legal, accounting and financial services firms, and he serves as U.S. counsel to international clients in connection with their acquisitions of U.S. companies.
Best Lawyers recognizes Hunter as a leading attorney in the area of Mergers and Acquisitions Law.
Experience
· Represented AIM-listed biotechnology company Silence Therapeutics (AIM:SLN) in its $25 million acquisition of Intradigm Corporation
· Represented Mumbai, India-based pharmaceutical firm Piramal Healthcare in its $40 million acquisition of Minrad International (NYSE:BUF), a U.S. pharmaceuticals manufacturer
· Represented Mumbai, India-based pharmaceutical firm Piramal Healthcare in its $4.2 million acquisition of RxElite (OTCBB:RXEI), a U.S. pharmaceuticals distributor
· Represented one of the nation's leading revenue cycle management companies, in its private equity recapitalization and multiple acquisitions
· Represented national healthcare technology provider in its acquisition of revenue cycle management firm along with its claims consulting and outsourcing subsidiary. Also represented client in connection with acquisition funding
· Represented international biopharmaceutical company in its $25 million acquisition of a private U.S.-based drug development and manufacturing company
Professional
· Member, American Bar Association
· Member, Tennessee and Nashville Bar Associations
· Member, International Law, Business Law and Health Law Sections of the American Bar Association and the Corporate Governance and Legal Opinions Committees of the ABA Business Law Section
· Member, American Health Lawyers Association, Life Sciences Practice Group
· Member, Life Science Tennessee
· Member, World Services Group, an international association of leading legal, accounting and financial services professionals
· Member, Waller Lansden Legal Opinions Committee
News/Events
ARTICLES
01.14.11, BIOTECH & PHARMACEUTICALS, "US Healthcare Reform Reflects Changing Life Sciences Industry"
BULLETINS
07.07.10, Gulf Oil Spill Likely to Spur Energy Sector Consolidation
Community
· Advisory Board Member and Past-Chair of the Sexual Assault Center, Nashville, Tennessee
Upclose
Hunter spending time with his family, coaching youth sports, cycling and enjoying the scenery at Center Hill Lake. When he can, he also likes to visit Manchester, Tennessee in June with 80,000 or so of his closest friends at Bonnaroo.